In high-grade gliomas, immunohistochemical data based on the isocitrate–dehydrogenase (IDH) mutation status in a previous study revealed that glial tumor cells migrate into multiple brain regions, including the contralesional hemisphere, and redefined glioma as a whole-brain disease rather than a focal brain disease (20). The gene discussed is IDH1; the disease is brain disorder.